Insights and lessons from a scientific conference on non-invasive delivery of macromolecules

Ronak Savla, Randall J. Mrsny, Kinam Park, Isabelle Aubert, Cornell Stamoran

Research output: Contribution to journalComment/debate

Abstract

A growing share of the pharmaceutical development pipeline is occupied by macromolecule drugs, which are primarily administered by injection. Despite decades of attempts, non-invasive delivery of macromolecules has seen only a few success stories. Potential benefits of non-invasive administration include better patient acceptance and adherence and potentially better efficacy and safety. Greater inter-disciplinary dialogue and collaboration are integral to realizing these benefits.

Original languageEnglish
Pages (from-to)1149-1151
Number of pages3
JournalPharmaceutical Research
Volume34
Issue number6
Early online date6 Apr 2017
DOIs
Publication statusPublished - 1 Jun 2017

Fingerprint

Macromolecules
Patient Compliance
Pharmaceutical Preparations
Pipelines
Safety
Injections

Keywords

  • blood-brain barrier
  • drug delivery
  • in vitro models
  • macromolecules
  • permeation enhancers

ASJC Scopus subject areas

  • Biotechnology
  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science
  • Organic Chemistry
  • Pharmacology (medical)

Cite this

Insights and lessons from a scientific conference on non-invasive delivery of macromolecules. / Savla, Ronak; Mrsny, Randall J.; Park, Kinam; Aubert, Isabelle; Stamoran, Cornell.

In: Pharmaceutical Research, Vol. 34, No. 6, 01.06.2017, p. 1149-1151.

Research output: Contribution to journalComment/debate

Savla, Ronak ; Mrsny, Randall J. ; Park, Kinam ; Aubert, Isabelle ; Stamoran, Cornell. / Insights and lessons from a scientific conference on non-invasive delivery of macromolecules. In: Pharmaceutical Research. 2017 ; Vol. 34, No. 6. pp. 1149-1151.
@article{8911116e74c642478a20ee98a2d8b64a,
title = "Insights and lessons from a scientific conference on non-invasive delivery of macromolecules",
abstract = "A growing share of the pharmaceutical development pipeline is occupied by macromolecule drugs, which are primarily administered by injection. Despite decades of attempts, non-invasive delivery of macromolecules has seen only a few success stories. Potential benefits of non-invasive administration include better patient acceptance and adherence and potentially better efficacy and safety. Greater inter-disciplinary dialogue and collaboration are integral to realizing these benefits.",
keywords = "blood-brain barrier, drug delivery, in vitro models, macromolecules, permeation enhancers",
author = "Ronak Savla and Mrsny, {Randall J.} and Kinam Park and Isabelle Aubert and Cornell Stamoran",
year = "2017",
month = "6",
day = "1",
doi = "10.1007/s11095-017-2156-9",
language = "English",
volume = "34",
pages = "1149--1151",
journal = "Pharmaceutical Research",
issn = "0724-8741",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Insights and lessons from a scientific conference on non-invasive delivery of macromolecules

AU - Savla, Ronak

AU - Mrsny, Randall J.

AU - Park, Kinam

AU - Aubert, Isabelle

AU - Stamoran, Cornell

PY - 2017/6/1

Y1 - 2017/6/1

N2 - A growing share of the pharmaceutical development pipeline is occupied by macromolecule drugs, which are primarily administered by injection. Despite decades of attempts, non-invasive delivery of macromolecules has seen only a few success stories. Potential benefits of non-invasive administration include better patient acceptance and adherence and potentially better efficacy and safety. Greater inter-disciplinary dialogue and collaboration are integral to realizing these benefits.

AB - A growing share of the pharmaceutical development pipeline is occupied by macromolecule drugs, which are primarily administered by injection. Despite decades of attempts, non-invasive delivery of macromolecules has seen only a few success stories. Potential benefits of non-invasive administration include better patient acceptance and adherence and potentially better efficacy and safety. Greater inter-disciplinary dialogue and collaboration are integral to realizing these benefits.

KW - blood-brain barrier

KW - drug delivery

KW - in vitro models

KW - macromolecules

KW - permeation enhancers

UR - http://www.scopus.com/inward/record.url?scp=85017170029&partnerID=8YFLogxK

UR - http://dx.doi.org/10.1007/s11095-017-2156-9

U2 - 10.1007/s11095-017-2156-9

DO - 10.1007/s11095-017-2156-9

M3 - Comment/debate

VL - 34

SP - 1149

EP - 1151

JO - Pharmaceutical Research

JF - Pharmaceutical Research

SN - 0724-8741

IS - 6

ER -